These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29173014)

  • 1. Initiation and completion rates of inactivated hepatitis A vaccination among children born between 2005 and 2014 in Zhejiang province, east China.
    Hu Y; Chen Y; Hui L; Wang Y
    Hum Vaccin Immunother; 2018 Apr; 14(4):1013-1017. PubMed ID: 29173014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initiation & completion rates of hepatitis A vaccination among US pediatric populations born between 2005 and 2009.
    Weiss T; Zhang D; Borse NN; Walter EB
    Vaccine; 2015 Nov; 33(48):6871-7. PubMed ID: 26259541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B Vaccination among 1999⁻2017 Birth Cohorts in Zhejiang Province: The Determinants Associated with Infant Coverage.
    Hu Y; Chen Y; Wang Y; Liang H
    Int J Environ Res Public Health; 2018 Dec; 15(12):. PubMed ID: 30572681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An Evaluation of Voluntary Varicella Vaccination Coverage in Zhejiang Province, East China.
    Hu Y; Chen Y; Zhang B; Li Q
    Int J Environ Res Public Health; 2016 Jun; 13(6):. PubMed ID: 27271649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seven-year follow-up of the immune response after one or 2 doses of inactivated hepatitis A vaccine given at 1 year of age in the Mendoza Province of Argentina.
    Espul C; Benedetti L; Linares M; Cuello H; Lo Castro I; Thollot Y; Rasuli A
    Hum Vaccin Immunother; 2017 Nov; 13(11):2707-2712. PubMed ID: 28933624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of potentially achievable vaccination coverage of the second dose of measles containing vaccine with simultaneous administration and risk factors for missed opportunities among children in Zhejiang province, east China.
    Hu Y; Chen Y; Wang Y; Liang H
    Hum Vaccin Immunother; 2018 Apr; 14(4):875-880. PubMed ID: 29252094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China.
    Liu XE; Wushouer F; Gou A; Kuerban M; Li X; Sun Y; Zhang J; Liu Y; Li J; Zhuang H
    Hum Vaccin Immunother; 2013 Jul; 9(7):1460-5. PubMed ID: 23571173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of hepatitis A antibody among population covered by different hepatitis A immunization strategies in Shandong Province, 2015, China].
    Kong Q; Yan BY; Lyu JJ; Feng Y; Liu JY; Song LZ; Xu Q; Zhang L; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Jun; 51(6):480-483. PubMed ID: 28592089
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose.
    Fiore AE; Shapiro CN; Sabin K; Labonte K; Darling K; Culver D; Bell BP; Margolis HS
    Pediatr Infect Dis J; 2003 Apr; 22(4):354-9. PubMed ID: 12690277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling the long-term persistence of hepatitis A antibody after a two-dose vaccination schedule in Argentinean children.
    López EL; Contrini MM; Mistchenko A; Kieffer A; Baggaley RF; Di Tanna GL; Desai K; Rasuli A; Armoni J
    Pediatr Infect Dis J; 2015 Apr; 34(4):417-25. PubMed ID: 25764099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Duration of protection against hepatitis A for the current two-dose vaccine compared to a three-dose vaccine schedule in children.
    Raczniak GA; Thomas TK; Bulkow LR; Negus SE; Zanis CL; Bruce MG; Spradling PR; Teshale EH; McMahon BJ
    Vaccine; 2013 Apr; 31(17):2152-5. PubMed ID: 23470239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response.
    Mayorga O; Bühler S; Jaeger VK; Bally S; Hatz C; Frösner G; Protzer U; Van Damme P; Egger M; Herzog C
    J Infect Dis; 2016 Nov; 214(10):1498-1506. PubMed ID: 27601623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up.
    Sharapov UM; Bulkow LR; Negus SE; Spradling PR; Homan C; Drobeniuc J; Bruce M; Kamili S; Hu DJ; McMahon BJ
    Hepatology; 2012 Aug; 56(2):516-22. PubMed ID: 22371069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the free-vaccine policy on timely initiation and completion of hepatitis B vaccination in Fujian, China.
    Wu JN; Wen XZ; Zhou Y; Lin D; Zhang SY; Yan YS
    J Viral Hepat; 2015 Jun; 22(6):551-60. PubMed ID: 25377649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-dose seasonal influenza vaccine coverage and timeliness among children aged 6 months through 3 years: An evidence from the 2010-11 to the 2014-15 seasons in Zhejiang province, east China.
    Hu Y; Chen Y; Zhang B
    Hum Vaccin Immunother; 2017 Jan; 13(1):75-80. PubMed ID: 27624854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of an accelerated vaccination regime with a combined hepatitis a/b vaccine in patients with chronic hepatitis C.
    Kallinowski B; Jilg W; Buchholz L; Stremmel W; Engler S
    Z Gastroenterol; 2003 Oct; 41(10):983-90. PubMed ID: 14562195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
    Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine vaccination coverage of children aged 1-7 years in Zhejiang province, China.
    Hu Y; Chen Y; Liang H; Wang Y
    Hum Vaccin Immunother; 2018; 14(12):2876-2883. PubMed ID: 30047821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with the inactivated hepatitis A vaccine, Avaxim 80U Pediatric.
    Bravo C; Mege L; Vigne C; Thollot Y
    Expert Rev Vaccines; 2019 Mar; 18(3):209-223. PubMed ID: 30806110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
    Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.